Surgical resection of late-stage hepatocellular carcinoma for patients having undergone combined HAIC, targeted and immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surgical resection of late-stage hepatocellular carcinoma for patients having undergone combined HAIC, targeted and immunotherapy

Published:2024-01 Issue:1 Volume:47 Page:523-524
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Sun Ruirui^ORCID,He Qiang,Pan Long,Huang Ping

Publisher

Elsevier BV

Subject

Surgery

Reference5 articles.

1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019;Global Burden of Disease 2019 Cancer Collaboration;JAMA Oncol,2022

2. Conversion surgery for hepatocellular carcinoma in the new era of targeted and immune checkpoint inhibitor therapies;Zhao;Hepatobiliary Surg Nutr,2020

3. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma;Zhou;Biosci Trends,2021

4. Application of multidisciplinary team in the conversion therapies of liver cancer[J];Guo;CHSM,2021

5. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib;Yang;Liver Int,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP